SLG
MLAB icon

Stanley-Laman Group’s Mesa Laboratories MLAB Stock Holding History

Stanley-Laman Group’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-11,442
Closed -$899K – 334
2013
Q4 		$899K Buy
+11,442
New +$834K 0.2% 118

Other funds holding MLAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bares Capital Management Austin, Texas $1.08B AUM 38.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Stanley-Laman Group's MLAB Position: Q1 2014 in Review

Stanley-Laman Group sold out of Mesa Laboratories (MLAB) in Q1 2014, closing a stake of 11,442 shares — an estimated $899K sold.

Stanley-Laman Group first reported a position in MLAB in Q4 2013 and held it in 1 quarter. The position peaked at $899K in Q4 2013. 66 funds tracked by Wall St. Rank hold MLAB as of Q1 2014.

  • Stanley-Laman Group reported no remaining Mesa Laboratories position as of Q1 2014 after selling out during the quarter.
  • Stanley-Laman Group sold 11,442 Mesa Laboratories shares in Q1 2014, an estimated $899K.
  • Stanley-Laman Group first reported a position in Mesa Laboratories in Q4 2013 and held it in 1 quarter.
  • Stanley-Laman Group's Mesa Laboratories position peaked at $899K in Q4 2013.
  • 66 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2014.

Based on Stanley-Laman Group's 13F filing for Q1 2014, filed 11 Apr 2014.